Abstract: A microparticle for cell encapsulation is provided, having a core which comprises continuous fibers of decellularized extracellular matrix (ECM) and, optionally, an outer layer. Also provided are methods of encapsulating cells in the microparticle, pharmaceutical compositions comprising the microparticle, and methods of treating disease in animals employing the microparticles of the invention, for example, treating Diabetes.

Abstract: Various examples are provided for brightness compensation in a display. In one example, a method includes identifying an IR voltage drop effect on a pixel supplied by a supply voltage line and generating a brightness signal for the pixel based at least in part on the IR voltage drop effect. In another example, a method includes calculating values of IR voltage drop corresponding to pixels fed by a common supply voltage line and providing a data line signal to each pixel that compensates for the IR voltage drop. In another example, a display device includes a matrix of pixels and a brightness controller configured to determine an IR voltage drop effect on a pixel of the matrix and generate a brightness signal for the pixel based at least in part on the IR voltage drop effect and a temporal average pixel brightness within one refreshing cycle associated with the pixel.

Abstract: Disclosed is a rear-view camera system for a vehicle. The rear-view camera system for a vehicle according to one embodiment of the present invention includes at least one wide-angle lens and at least one standard lens, and may take a rear image of the vehicle using the wide-angle lens or the standard lens. According to the embodiment of the present invention, it is possible to reduce an accident risk, while the vehicle is reversing, by providing an image taken through the wide-angle lens or an image taken through the standard lens according to a distance between the vehicle and an object located at a rear thereof or a user's selection, and also to observe rules of parking etiquette without any difficulty.

Abstract: An anti-fungal composition for the control of one or more target fungi (or a similar heterotrophic, hyphae-producing organism) that infect plant materials and are(is) separately controllable by a benzoxaborole and an anti-fungal compound of a preselected FRAC Target Site Code is disclosed, as is a method of its use. A composition contains a diluent medium having dissolved or dispersed therein a synergistic effective amount of each of a first and a second anti-fungal compound. The first anti-fungal compound is a benzoxaborole of Formula I. The second anti-fungal compound is other than a benzoxaborole and is known to control said one or more target species of fungus when utilized as the sole anti-fungal compound at a concentration greater than the synergistic effective amount and has a preselected FRAC Target Site Code of B, C, D, E, G, H, or M.

Abstract: The present invention relates to polydixylitol polymer based gene transporter (PdXYP) and a preparation method thereof. Further, the present invention relates to a nucleic acid delivery complex where the nucleic acids for treatment are conjugated to the gene transporter and a pharmaceutical composition for gene therapy including the complex as an active ingredient. In addition, the present invention relates to the gene transporter, gene delivery complex, and gene therapy using the gene transporter and gene delivery complex. It was confirmed that the PdXYP of the present invention has a considerably higher nucleic acid delivery rate than existing gene transporters, has almost no cytotoxicity in the conjugate when conjugated with DNA, also has very high in vivo transfection efficiency, and above all, especially has considerably high transfection efficiency for brain tissues, which has involved difficulty in gene therapy due to the blood brain barrier for a while.

Abstract: A method of forming a low dielectric constant (low-k) dielectric is disclosed. The method includes providing a substrate and forming a dielectric including porogens over the substrate. While subjecting the dielectric to a first pressure, the dielectric is exposed to ultraviolet (UV) radiation. The dielectric is also subject to a second pressure less than 1×10?3 Torr. While subjecting the dielectric to the second pressure, the dielectric is exposed to vacuum UV (VUV) radiation having one or more photon energies greater than 7 eV. Since it is difficult for VUV radiation to travel through a medium at a pressure greater than 10 Torr without being absorbed by intermittent materials, subjecting the dielectric to the second pressure creates a medium wherein the dielectric can be exposed to the VUV radiation. By exposing the dielectric to UV and VUV radiation, the dielectric can achieve a reduced dielectric constant and increased mechanical properties.

Abstract: A condensed cyclic compound represented by Formula 1 and an organic light-emitting device including the condensed cyclic compound are provided;

Abstract: Described here are systems and methods for efficiently simulating wave propagation in one or more viscoelastic media. The systems and methods described here implement an elastodynamic model that includes memory variables for one or more viscoelastic properties. Boundary conditions can also be generated based on a perfectly matched layer (PML) condition. A hybrid implicit/explicit method is used to generate wave simulation data. In this method, equations related to the memory variables and PML are solved using an implicit integrator, and other equations in the elastodynamic model are solved using an explicit method.

Abstract: The present invention relates to a diketopyrrolopyrrole polymer, which is an organic semiconductor compound for an organic electronic device, and a use thereof. The diketopyrrolopyrrole polymer according to the present invention is a novel organic semiconductor compound having high ?-electron stacking by introducing an electron donor compound, and an organic electronic device employing the same has excellent charge mobility and on/off ratio.

Abstract: A bracket assembly for a brake assembly and a brake actuator includes a tube configured to receive a camshaft of the brake assembly. A brake spider mounting flange and actuator mounting arm are disposed proximate opposite ends of the tube and configured for coupling to a brake spider and the actuator. The arm has inboard and outboard members—each with a body having one end affixed to the tube and an actuator mounting flange extending from another end of the body. The mounting flanges define aligned bores configured to receive a fastener of the actuator. A centerline of a gusset joining the body and flange of the inboard member is angled relative to at least one of a plane containing a longitudinal axis of the tube and a plane containing a load path line joining the center points of a tube bore and pushrod notch formed in the inboard member.

Abstract: The present invention relates to a method of increasing resistance against plant pathogens, particularly Fusarium virguliforme and Phytophthora sojae in transgenic plants and/or plant cells, through the use of non host resistance nucleic acid molecules isolated from Arabidopsis. In these plants, at least one nonhost Arabidopsis resistance protein is introduced in comparison to the wild-type plants to confer resistance to plant pathogens. The invention relates to transgenic plants and/or plant cells having increased resistance to plant pathogens, particularly Fusarium virguliforme and Phytophthora sojae, to expression vectors, transformed plants and plant cells as well as the use of such plants in a plant breeding program.

Abstract: The present invention relates to a method of increasing plant resistance to plant pathogens, particularly Sudden Death Syndrome in soybean against Fusarium virguliforme, through the use of Fusarium resistance nucleic acid molecules isolated from Glycine max and Fusarium virguliforme. In these plants, at least one heterologous Fusarium resistance protein is introduced in comparison to the wild-type plants to confer resistance to plant pathogens. The invention relates to transgenic plants and/or plant cells having increased resistance to plant pathogens, to expression vectors, transformed plants and plant cells as well as the use of such plants in a plant breeding program.

Abstract: A method of manufacturing a pellicle includes preparing a pellicle frame having an adhesive layer coated thereon, treating a pellicle membrane with vapor under vapor atmosphere, attaching the pellicle membrane onto the pellicle frame, and drying the pellicle membrane.

Abstract: Disclosed herein are compounds, compositions and methods for modulating the expression of huntingtin in a cell, tissue or animal. Further provided are methods of slowing or preventing Huntington's disease progression using an antisense compound targeted to huntingtin. Additionally provided are methods of delaying or preventing the onset of Huntingtin's disease in an individual susceptible to Huntingtin's Disease. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.

Abstract: Compositions and methods for reducing the level of nornicotine and N?-nitrosonornicotine (NNN) in Nicotiana plants and plant parts thereof are provided. The compositions comprise isolated polynucleotides and polypeptides for cytochrome P450s that are involved in the metabolic conversion of nicotine to nornicotine in these plants. Expression cassettes, vectors, plants, and plant parts thereof comprising inhibitory sequences that target expression or function of the disclosed cytochrome P450 polypeptides are also provided. Methods for the use of these novel sequences to inhibit expression or function of cytochrome P450 polypeptides involved in this metabolic conversion are also provided. The methods find use in the production of tobacco products that have reduced levels of nornicotine and its carcinogenic metabolite, NNN, and thus reduced carcinogenic potential for individuals consuming these tobacco products or exposed to secondary smoke derived from these products.

Abstract: This document relates to materials and methods in assessing and treating mammals (e.g., humans) with precursor plasma cell (PC) disorders. Materials and methods for determining if a mammal (e.g., a mammal having a precursor plasma cell disorder) has an elevated level of 2-hydroxyglutarate (2-HG) that can be used to identify the precursor plasma cell disorder as likely to progress to a PC cancer (e.g., multiple myeloma) are provided. Materials and methods for treating a mammal having a precursor PC disorder at high risk of progressing to a PC cancer also are provided.

Abstract: An implantable pressure sensor arrangement is disclosed. The arrangement includes a substrate, a coil positioned on the substrate, a flexible membrane positioned proximate to the coil and configured to be moveable with respect to the coil, thereby forming a fluid chamber, fluidly sealed from outside of the implantable pressure sensor arrangement, a porous membrane positioned on the flexible membrane and configured to transfer pressure from outside of the implantable pressure sensor arrangement onto the flexible membrane wherein a differential pressure is generated on the two sides of the flexible membrane thereby causing the flexible membrane to deflect towards and away from the coil, and an electrode coupled to the flexible membrane.

Abstract: Provided a method and system for computing a bandwidth requirement for a cellular operator from shared spectrum in a cellular network, the shared spectrum comprising at least one shared spectrum class which is accessible by multiple entities, the method comprising: computing an average user throughput in the cellular network; comparing the average user throughput to a target minimum average user throughput, taking into account an average percentage of users within coverage and a coverage probability threshold; and based on the comparison, computing an additional bandwidth requirement from the at least one shared spectrum class.

Abstract: Provided herein are compounds of Formula (I) and pharmaceuticals acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, and prodrugs thereof. Also provided are pharmaceutical compositions, kits, and methods involving the inventive compounds for the treatment of an infectious disease (e.g., bacterial infection (e.g., tuberculosis, methicillin-resistant Staphylococcus aureus).

Abstract: A touch control system for a vehicle may include a detector portion disposed on a head lining of a vehicle, and a communication module configured to receive a signal from the detector portion and transmit the signal to a device to be controlled by the signal.